Macrophage-specific inhibition of NF-κB activation reduces foam-cell formation

Atherosclerosis

Volumn 192, Issue 2, 2007, Pages 283-290

  Ferreira, Valérie ^a   van Dijk, Ko Willems ^b   Groen, Albert K ^a   Vos, Rogier M ^a   van der Kaa, Jos ^b   Gijbels, Marion J J ^d   Havekes, Louis M ^b,c   Pannekoek, Hans ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c TNO   (Netherlands)

^d MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

ABCA1 mediated cholesterol efflux; Foam cell formation; Macrophage specific inhibition of NF B, I B ; ox LDL PPAR CD36 "feed forward cycle"

Indexed keywords

I KAPPA B KINASE ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ARTICLE; CELL DIFFERENTIATION; CELL LINE; CELL SPECIFICITY; CONTROLLED STUDY; CYTOPLASM; FOAM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; LIPID OXIDATION; LIPID TRANSPORT; MONOCYTE; MOUSE; NONHUMAN; PERITONEUM CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD36; ATP-BINDING CASSETTE TRANSPORTERS; CELL LINE; DNA-BINDING PROTEINS; FOAM CELLS; HUMANS; I-KAPPA B PROTEINS; LIPOPROTEINS, LDL; MACROPHAGES; MICE; MICE, INBRED C57BL; NF-KAPPA B; PPAR GAMMA; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SCAVENGER RECEPTORS, CLASS A;

EID: 34248209613     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2006.07.018     Document Type: Article

References (29)

1. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115-126
2. Davies P.F. Flow-mediated endothelial mechanotransduction. Physiol Rev 75 (1995) 519-560
3. Karin M. The beginning of the end: IkappaB kinase (IKK) and NF-kappaB activation. J Biol Chem 274 (1999) 27339-27342
4. Baldwin A.S. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 14 (1996) 649-683
5. Baeuerle P.A., and Baltimore D. NF-kappa B: ten years after. Cell 87 (1996) 13-20
6. Palombella V.J., Rando O.J., Goldberg A.L., and Maniatis T. The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B. Cell 78 (1994) 773-785
7. Scherer D.C., Brockman J.A., Chen Z., Maniatis T., and Ballard D.W. Signal-induced degradation of I kappa B alpha requires site-specific ubiquitination. Proc Natl Acad Sci USA 92 (1995) 11259-11263
8. Finco T.S., and Baldwin A.S. Mechanistic aspects of NF-kappa B regulation: the emerging role of phosphorylation and proteolysis. Immunity 3 (1995) 263-272
9. Traenckner E., Pahl H., Henkel T., et al. Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli. EMBO J 14 (1995) 2876-2883
10. Ferreira V., Tarantino N., and Korner M. Discrimination between RelA and RelB transcriptional regulation by a dominant negative mutant of IkappaBalpha. J Biol Chem 273 (1998) 592-599
11. Ferreira V., Sidenius N., Tarantino N., et al. In vivo inhibition of NF-kappa B in T-lineage cells leads to a dramatic decrease in cell proliferation and cytokine production and to increased cell apoptosis in response to mitogenic stimuli, but not to abnormal thymopoiesis. J Immunol 162 (1999) 6442-6450
12. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362 (1993) 801-809
13. Baeuerle P.A., and Henkel T. Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 12 (1994) 141-179
14. Brand K., Page S., Rogler G., et al. Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J Clin Invest 97 (1996) 1715-1722
15. Kanters E., Gijbels M.J., van der Made I., et al. Hematopoietic NF-kappaB1 deficiency results in small atherosclerotic lesions with an inflammatory phenotype. Blood 103 (2004) 934-940
16. Kanters E., Pasparakis M., Gijbels M.J., et al. Inhibition of NF-kappaB activation in macrophages increases atherosclerosis in LDL receptor-deficient mice. J Clin Invest 112 (2003) 1176-1185
17. Bouwmeester T., Bauch A., Ruffner H., et al. A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway. Nat Cell Biol 6 (2004) 97-105
18. Auwerx J. The human leukemia cell line, THP-1: a multifacetted model for the study of monocyte-macrophage differentiation. Experientia 47 (1991) 22-31
19. Mikita T., Porter G., Lawn R.M., and Shiffman D. Oxidized low density lipoprotein exposure alters the transcriptional response of macrophages to inflammatory stimulus. J Biol Chem 276 (2001) 45729-45739
20. Febbraio M., Hajjar D.P., and Silverstein R.L. CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J Clin Invest 108 (2001) 785-791
21. Joseph S.B., Castrillo A., Laffitte B.A., Mangelsdorf D.J., and Tontonoz P. Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat Med 9 (2003) 213-219
22. Horvai A., Palinski W., Wu H., et al. Scavenger receptor A gene regulatory elements target gene expression to macrophages and to foam cells of atherosclerotic lesions. Proc Natl Acad Sci USA 92 (1995) 5391-5395
23. Moore K.J., Rosen E.D., Fitzgerald M.L., et al. The role of PPAR-gamma in macrophage differentiation and cholesterol uptake. Nat Med 7 (2001) 41-47
24. Chawla A., Barak Y., Nagy L., et al. PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation. Nat Med 7 (2001) 48-52
25. Chinetti G., Lestavel S., Bocher V., et al. PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway. Nat Med 7 (2001) 53-58
26. Repa J.J., Turley S.D., Lobaccaro J.A., et al. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science 289 (2000) 1524-1529
27. Lee C.H., and Evans R.M. Peroxisome proliferator-activated receptor-gamma in macrophage lipid homeostasis. Trends Endocrinol Metab 13 (2002) 331-335
28. Llodra J., Angeli V., Liu J., et al. Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques. Proc Natl Acad Sci USA 101 (2004) 11779-11784
29. Gerbod-Giannone M.C., Li Y., Holleboom A., et al. TNFα induces ABCA1 through NF-kB in macrophages and in phagocytes ingesting apoptotic cells. Proc Natl Acad Sci USA 103 (2006) 3112-3117